Description
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Product Unit Size | Cost | Quantity | Stock |
|---|
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Cas No. | 1258595-14-0 |
|---|---|
| Purity | ≥99% |
| Formula | C29H32F2N3O7P |
| Formula Wt. | 603.56 |
| IUPAC Name | 3-[5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]benzo[f][1,7]naphthyridin-8-yl]propanoic acid |
| Synonym | LHC165 |
| Appearance | Pale yellow powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Zawit M, Swami U, Awada H, et al. Current status of intralesional agents in treatment of malignant melanoma. Ann Transl Med. 2021 Jun;9(12):1038. PMID: 34277838
Steroid; glucocorticoid agonist.
Steroid lactone produced by Withania somnifera;...
Polyvinyl pyrrolidone polymer, disinfectant.
ITC, erysolin analog.
Furanolactone found in citrus fruits.
Benzisoxazole; 5-HT7 and NMDA agonist, D-amino ...
RAD51 inhibitor.
Read-through agent and nonsense mutation target...
Imidazole; 14-α demethylase inhibitor, potenti...
NO donor.
p110α inhibitor.
Endogenous peptide hormone fragment, involved i...
Phenothiazine; D1/2 and α1-adrenergic antagoni...
Thalidomide derivative; cereblon and TNF-α inh...
β-adrenergic antagonist, voltage-gated Na+ and...
Macrolide lactone found in Bugula; TLR4 activat...
SHP2 inhibitor
σ2 agonist.
DHF reductase inhibitor.
Ellagic acid derivative produced by gut microfl...